Literature DB >> 20807519

Attenuation of cannabinoid-induced inhibition of medullary dorsal horn neurons by a kappa-opioid receptor antagonist.

Akiko Okada-Ogawa1, Masayuki Kurose, Ian D Meng.   

Abstract

The kappa-opioid receptor (KOR) antagonist norbinaltorphimine (nor-BNI) attenuates behavioral antinociception produced by spinal administration of the cannabinoid receptor agonist delta-9-tetrahydorcannabinol (THC). The present study examined the ability of nor-BNI to prevent cannabinoid-induced inhibition of medullary dorsal horn (MDH) nociceptive neurons and antinociception produced by the cannabinoid agonist WIN 55,212-2 (WIN-2). Extracellular, single-unit recordings of lamina I and lamina V MDH neurons were performed in urethane anesthetized rats. Heat-evoked activity was measured before and after local brainstem application of nor-BNI or vehicle followed by WIN-2. In both lamina I and lamina V neurons, prior application of nor-BNI prevented the inhibition of heat-evoked activity by WIN-2. In separate experiments, the contribution of KOR to cannabinoid-induced increases in heat-evoked head withdrawal latencies was assessed in lightly urethane-anesthetized rats. Antinociception produced by intrathecal administration of WIN-2 and THC was attenuated by prior administration of nor-BNI. In contrast, antinociception produced by the cannabinoid CP55940 remained unaffected by prior administration of nor-BNI. These results indicate that cannabinoid inhibition of nociceptive reflexes produced by WIN-2 and THC may result from inhibition of dorsal horn neurons through a KOR-dependent mechanism.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807519      PMCID: PMC3166581          DOI: 10.1016/j.brainres.2010.08.073

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  45 in total

1.  The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.

Authors:  G Pugh; P B Smith; D S Dombrowski; S P Welch
Journal:  J Pharmacol Exp Ther       Date:  1996-11       Impact factor: 4.030

2.  Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2.

Authors:  A G Hohmann; W J Martin; K Tsou; J M Walker
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

3.  Encoding of corneal input in two distinct regions of the spinal trigeminal nucleus in the rat: cutaneous receptive field properties, responses to thermal and chemical stimulation, modulation by diffuse noxious inhibitory controls, and projections to the parabrachial area.

Authors:  I D Meng; J W Hu; A P Benetti; D A Bereiter
Journal:  J Neurophysiol       Date:  1997-01       Impact factor: 2.714

4.  Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats.

Authors:  J C Xue; Y X Yu; J S Han; M F Jen
Journal:  Int J Neurosci       Date:  1995-05       Impact factor: 2.292

5.  Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects.

Authors:  W J Martin; A G Hohmann; J M Walker
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

6.  Local application of the cannabinoid receptor agonist, WIN 55,212-2, to spinal trigeminal nucleus caudalis differentially affects nociceptive and non-nociceptive neurons.

Authors:  Alex M Papanastassiou; Howard L Fields; Ian D Meng
Journal:  Pain       Date:  2004-02       Impact factor: 6.961

7.  Antisense oligodeoxynucleotides to the kappa-1 receptor block the antinociceptive effects of delta 9-THC in the spinal cord.

Authors:  G Pugh; M E Abood; S P Welch
Journal:  Brain Res       Date:  1995-08-14       Impact factor: 3.252

8.  Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.

Authors:  S P Welch; C Thomas; G S Patrick
Journal:  J Pharmacol Exp Ther       Date:  1995-01       Impact factor: 4.030

9.  Cannabinoid CB1 receptor inhibition of mechanically evoked responses of spinal neurones in control rats, but not in rats with hindpaw inflammation.

Authors:  Sara Kelly; Victoria Chapman
Journal:  Eur J Pharmacol       Date:  2003-08-08       Impact factor: 4.432

10.  Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrazone (NalBZH).

Authors:  S P Welch
Journal:  Pharmacol Biochem Behav       Date:  1994-12       Impact factor: 3.533

View more
  2 in total

Review 1.  Development of κ opioid receptor antagonists.

Authors:  F Ivy Carroll; William A Carlezon
Journal:  J Med Chem       Date:  2013-02-14       Impact factor: 7.446

2.  A non-opioid pathway for dynorphin-caused spinal cord injury in rats.

Authors:  Yu Chen; Liangbi Xiang; Jun Liu; Dapeng Zhou; Hailong Yu; Qi Wang; Wenfeng Han; Mingming Guo
Journal:  Neural Regen Res       Date:  2012-04-15       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.